ClinicalTrials.govpublic full text
Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
limb girdle muscular dystrophy type 2c, gamma-sarcoglycanopathy, gene therapy, aav vector, neuromuscular disease, orphan disease, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910356
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.